BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 16304802)

  • 1. [Current concepts of the antiplatelet and anticoagulant treatment in the prevention of stroke].
    Szapáry L
    Orv Hetil; 2005 Oct; 146(41):2095-101. PubMed ID: 16304802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anticoagulation and antiaggregation in neurological patients].
    Arnold M; Nedeltchev K; Mattle HP
    Ther Umsch; 2003 Jan; 60(1):33-5. PubMed ID: 12638476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clopidogrel hydrogen sulphate for atrial fibrillation.
    Garg N; Rajpurohit N; Flaker G
    Expert Opin Pharmacother; 2011 Aug; 12(11):1781-7. PubMed ID: 21663525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Aspirin and cerebral ischemic accidents].
    Crassard I; Niclot P; Bousser MG
    Rev Med Interne; 2000 Mar; 21 Suppl 1():41s-49s. PubMed ID: 10763204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Albers GW; Amarenco P; Easton JD; Sacco RL; Teal P
    Chest; 2008 Jun; 133(6 Suppl):630S-669S. PubMed ID: 18574275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplatelet drugs for ischemic stroke prevention.
    Leys D; Balucani C; Cordonnier C
    Cerebrovasc Dis; 2009; 27 Suppl 1():120-5. PubMed ID: 19342841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stroke prevention: antiplatelet and antithrombolytic therapy.
    Diener HC
    Haemostasis; 2000; 30 Suppl 3():14-26. PubMed ID: 11182625
    [No Abstract]   [Full Text] [Related]  

  • 8. Secondary prevention of stroke: a practical guide to drug treatment.
    Koennecke HC
    CNS Drugs; 2004; 18(4):221-41. PubMed ID: 15015903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial fibrillation and anticoagulation.
    Maxim R
    Med Health R I; 2001 Mar; 84(3):96-7. PubMed ID: 11280139
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
    Biller J
    J Neurol Sci; 2009 Sep; 284(1-2):1-9. PubMed ID: 19380153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation and platelet antiaggregation therapy in stroke prevention.
    Chong JY; Mohr JP
    Curr Opin Neurol; 2005 Feb; 18(1):53-7. PubMed ID: 15655403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of aspirin for stroke prevention in atrial fibrillation.
    Lip GY
    Nat Rev Cardiol; 2011 Jul; 8(10):602-6. PubMed ID: 21788962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing stroke in patients with atrial fibrillation: current treatments and new concepts.
    Connolly SJ
    Am Heart J; 2003 Mar; 145(3):418-23. PubMed ID: 12660663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Good old warfarin for stroke prevention in atrial fibrillation.
    Verheugt FW
    Lancet; 2006 Jun; 367(9526):1877-8. PubMed ID: 16765740
    [No Abstract]   [Full Text] [Related]  

  • 15. [Anticoagulation and antiaggregation in cardiac patients].
    Meyer BJ
    Ther Umsch; 2003 Jan; 60(1):27-32. PubMed ID: 12638475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
    Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The approach to optimizing stroke care.
    Panagos PD
    Am J Emerg Med; 2008 Sep; 26(7):808-16. PubMed ID: 18774049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: should we change our practice after the PIONEER AF-PCI and RE-DUAL PCI trials?
    Duerschmied D; Brachmann J; Darius H; Frey N; Katus HA; Rottbauer W; Schäfer A; Thiele H; Bode C; Zeymer U
    Clin Res Cardiol; 2018 Jul; 107(7):533-538. PubMed ID: 29679144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: A population-wide cohort study.
    Chan EW; Lau WC; Siu CW; Lip GY; Leung WK; Anand S; Man KK; Wong IC
    Heart Rhythm; 2016 Aug; 13(8):1581-8. PubMed ID: 27033342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current practice of antithrombotic treatment in ischemic stroke: a survey among Hungarian neurologists.
    Sztriha LK; Vécsei L
    Ideggyogy Sz; 2008 May; 61(5-6):148-54. PubMed ID: 18567389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.